Ann Marie Beddoe, MD, assistant professor of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Hospital, discusses the impact of cervical cancer screening for women in the United States.

Within the United States, there is a large immigrant population and women come from countries where they have not had formal or effective screening programs, states Beddoe.

According to Beddoe, it is important to be aggressive about your treatment and recommending HPV vaccines because, patients may not be in the country for a long time in terms of their migratory status.

Videos

Dr. Beddoe on the Impact of Cervical Cancer Screening

Ann Marie Beddoe, MD, assistant professor, Obstetrics, Gynecology and Reproductive Science, Gynecologic Oncology, Mount Sinai Hospital, discusses ongoing clinical trials for patients with cervical cancer.

Clinical trials focused on immunotherapy and vaccines that are currently ongoing are very intriguing potential treatment options for patients with cervical cancer, Beddoe explains. This would also be particularly beneficial for patients in underdeveloped countries, where cervical cancer is the most common cancer among women. Additionally, it is the prime cause of mortality for reproductive-age women in some of these developing countries, she adds.

While some of the technology available in the United States is not yet available in some of these other areas, it is an active area of research, she says.

Ann Marie Beddoe, MD

Articles

Dr. Beddoe on the Impact of Cervical Cancer Screening

Dr. Beddoe on Ongoing Trials for Patients With Cervical Cancer